Supplemental Figures
Figure S1. Evolution of IL10 secreting Bregs in CG, RP and NRP during 1-year of AIT. A) Flow Cytometry strategy followed to define Bregs and IL10 secreting Bregs. B) Individual data points and box plots representing the median and IQR of the percentage of IL10 + Breg for each time point. We can observe a tendency suggesting a potential increase in RP patients during AIT, although this was not significant. Positive and negative gates were determined using isotypic controls for each antibody. 
